Jeff Leiden (via YouTube)

Got a rev­o­lu­tion­ary health­care com­pa­ny? Bob Nelsen, Jeff Lei­den’s SPAC has $500M to take it pub­lic

ARCH Ven­tures doesn’t hold back when it can go big in biotech VC in­vest­ments. The same seems to be hold­ing true when it comes to SPACs.

Rev­o­lu­tion Health­care Ac­qui­si­tion, the blank check com­pa­ny ARCH formed in part­ner­ship with the tech play­er Gen­er­al Cat­a­lyst, raised the $500 mil­lion it asked for in an IPO. The two firms had made it clear that they will be look­ing to take a dig­i­tal health com­pa­ny pub­lic — with the end goal be­ing part of a par­a­digm shift in­volv­ing “tech­nolo­gies like wear­able sen­sors, re­mote con­tin­u­ous da­ta cap­ture, point of care di­ag­nos­tics, tele­health ca­pa­bil­i­ties and ar­ti­fi­cial in­tel­li­gence/ma­chine learn­ing tools.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.